Literature DB >> 31782771

Mitochondrial transplantation for myocardial protection in diabetic hearts.

Ilias P Doulamis1, Alvise Guariento1, Thomas Duignan1, Arzoo Orfany1, Takashi Kido1, David Zurakowski1, Pedro J Del Nido1, James D McCully1.   

Abstract

OBJECTIVES: Type 2 diabetes causes mitochondrial dysfunction, which increases myocardial susceptibility to ischaemia-reperfusion injury. We investigated the efficacy of transplantation of mitochondria isolated from diabetic or non-diabetic donors in providing cardioprotection from warm global ischaemia and reperfusion in the diabetic rat heart.
METHODS: Ex vivo perfused hearts from Zucker diabetic fatty (ZDF fa/fa) rats (n = 6 per group) were subjected to 30 min of warm global ischaemia and 120 min reperfusion. Immediately prior to reperfusion, vehicle alone (VEH) or vehicle containing mitochondria isolated from either ZDF (MTZDF) or non-diabetic Zucker lean (ZL +/?) (MTZL) skeletal muscle were delivered to the coronary arteries via the aortic cannula.
RESULTS: Following 30-min global ischaemia and 120-min reperfusion, left ventricular developed pressure was significantly increased in MTZDF and MTZL groups compared to VEH group (MTZDF: 92.8 ± 5.2 mmHg vs MTZL: 110.7 ± 2.4 mmHg vs VEH: 44.3 ± 5.9 mmHg; P < 0.01 each); and left ventricular end-diastolic pressure was significantly decreased (MTZDF 12.1 ± 1.3 mmHg vs MTZL 8.6 ± 0.8 mmHg vs VEH: 18.6 ± 1.5 mmHg; P = 0.016 for MTZDF vs VEH and P < 0.01 for MTZL vs VEH). Total tissue ATP content was significantly increased in both MT groups compared to VEH group (MTZDF: 18.9 ± 1.5 mmol/mg protein/mg tissue vs MTZL: 28.1 ± 2.3 mmol/mg protein/mg tissue vs VEH: 13.1 ± 0.5 mmol/mg protein/mg tissue; P = 0.018 for MTZDF vs VEH and P < 0.01 for MTZL vs VEH). Infarct size was significantly decreased in the MT groups (MTZDF: 11.8 ± 0.7% vs MTZL: 9.9 ± 0.5% vs VEH: 52.0 ± 1.4%; P < 0.01 each).
CONCLUSIONS: Mitochondrial transplantation significantly enhances post-ischaemic myocardial functional recovery and significantly decreases myocellular injury in the diabetic heart.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Diabetes; Mitochondrial transplantation; Myocardial ischaemia–reperfusion injury

Mesh:

Year:  2020        PMID: 31782771     DOI: 10.1093/ejcts/ezz326

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  9 in total

Review 1.  Mitochondrial transfer/transplantation: an emerging therapeutic approach for multiple diseases.

Authors:  Zonghan Liu; Yi Sun; Zhengtang Qi; Lu Cao; Shuzhe Ding
Journal:  Cell Biosci       Date:  2022-05-19       Impact factor: 9.584

Review 2.  Multifaceted Roles of Mitochondrial Components and Metabolites in Metabolic Diseases and Cancer.

Authors:  Jean Nakhle; Anne-Marie Rodriguez; Marie-Luce Vignais
Journal:  Int J Mol Sci       Date:  2020-06-20       Impact factor: 5.923

Review 3.  Challenges in Promoting Mitochondrial Transplantation Therapy.

Authors:  Yuma Yamada; Momo Ito; Manae Arai; Mitsue Hibino; Takao Tsujioka; Hideyoshi Harashima
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

Review 4.  "Empowering" Cardiac Cells via Stem Cell Derived Mitochondrial Transplantation- Does Age Matter?

Authors:  Matthias Mietsch; Rabea Hinkel
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

5.  Mitochondrial Transfer Improves Cardiomyocyte Bioenergetics and Viability in Male Rats Exposed to Pregestational Diabetes.

Authors:  Eli J Louwagie; Tricia D Larsen; Angela L Wachal; Tyler C T Gandy; Michelle L Baack
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

6.  Extracellular vesicles fail to trigger the generation of new cardiomyocytes in chronically infarcted hearts.

Authors:  Bruna Lima Correa; Nadia El Harane; Manon Desgres; Maria Perotto; Paul Alayrac; Chloé Guillas; Laetitia Pidial; Valérie Bellamy; Emilie Baron; Gwennhael Autret; Keirththana Kamaleswaran; Chloé Pezzana; Marie-Cécile Perier; José Vilar; Antonio Alberdi; Alain Brisson; Nisa Renault; Massimiliano Gnecchi; Jean-Sébastien Silvestre; Philippe Menasché
Journal:  Theranostics       Date:  2021-11-02       Impact factor: 11.556

Review 7.  Mitochondrial Transfer in Cardiovascular Disease: From Mechanisms to Therapeutic Implications.

Authors:  Jun Chen; Jinjie Zhong; Lin-Lin Wang; Ying-Ying Chen
Journal:  Front Cardiovasc Med       Date:  2021-11-26

8.  Commentary: One plus one does not always equal two: Mitochondrial cardioprotection.

Authors:  Alvise Guariento; Ilias Doulamis; Vladimiro Vida
Journal:  JTCVS Open       Date:  2021-08-20

Review 9.  Mitochondrial transplantation in cardiomyocytes: foundation, methods, and outcomes.

Authors:  Paria Ali Pour; Sina Hosseinian; Arash Kheradvar
Journal:  Am J Physiol Cell Physiol       Date:  2021-06-30       Impact factor: 5.282

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.